Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration
Conditions
AMD · Age-Related Macular Degeneration
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UZ Brussel, Brussels, Belgium
Contact: Principal Investigator (Giuseppe Fasolino, MD)Centre d'Ophtalmologie Paradis-Monticelli, Marseille, France
Contact: Principal Investigator (Dr John Conrath, MD)Hélios Ophtalmologie, Saint-Jean-de-Luz, Saint-Jean-de-Luz, France
Contact: Principal Investigator (Dr Frédéric HAMON, MD)CHRU de Strasbourg, Strasbourg, France
Contact: Principal Investigator (Prof David Gaucher, MD)Augenklinik Städtisches Klinikum Karlsruhe, Karlsruhe, Germany
Universitätsklinikum Münster Klinik für Augenheilkunde, Münster, Germany
Contact: Principal Investigator (Nicole Eter, MD)Mater Misericordiae University Hospital, Dublin, Ireland
Contact: Principal Investigator (David Keegan, MD)Università degli Studi di Napoli Federico II, Naples, Italy
Contact: Principal Investigator (Mario Toro, MD)Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy
Contact: Principal Investigator (Stanislao Rizzo, MD)VISSUM, Alicante, Spain
Contact: Principal Investigator (Jorge Alio, MD)Institut OMIQ, Barcelona, Spain
Contact: Principal Investigator (Merce Guarro, MD)Hospital Universitario La Luz - Quirónsalud, Madrid, Spain
Contact: Principal Investigator (Juan Donate-López, MD)Royal Victoria Hospital Belfast Health & Social Care Trust, Belfast, United Kingdom
Contact: Principal Investigator (Guiliana Silvestri, MD)